Monroe Porter

Monroe Porter serves as a key procurement lead within the Defense Health Agency, overseeing acquisitions critical to sustaining operational medical readiness across the Department of Defense’s global healthcare network. Responsible for managing the acquisition lifecycle of pharmaceutical preparations and related clinical support systems, Porter ensures timely procurement of mission-critical medications, sterile compounding supplies, and integrated pharmaceutical delivery systems aligned with DHA’s clinical quality and supply chain resilience goals. His work directly supports the agency’s mandate to maintain uninterrupted access to FDA-approved therapeutics and advanced pharmaceutical formulations for service members, retirees, and their families. Porter maintains consistent contracting relationships with specialized vendors including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc., each providing niche capabilities in pharmaceutical handling, bioscience innovation, medical device integration, and sterile environment compliance. These partnerships reflect a focus on high-integrity suppliers with proven expertise in GMP-compliant manufacturing, controlled substance logistics, and clinical-grade sterilization technologies. His procurement approach emphasizes vendor reliability, regulatory adherence, and supply chain traceability over price alone. Porter’s contracting portfolio reflects a strict preference for full and open competition, with 100% of awards issued under no set-aside classifications. This indicates a deliberate strategy prioritizing technical capability and supply chain security over socioeconomic preferences, ensuring access to the highest-tier manufacturers capable of meeting Defense Health Agency’s stringent quality and regulatory standards. His primary procurement focus lies within NAICS 325412 — Pharmaceutical Preparation Manufacturing — encompassing sterile injectables, compounded formulations, and specialty drug products essential to military medical operations. Porter’s expertise centers on procuring complex pharmaceuticals requiring cold chain logistics, controlled substance controls, and FDA-validated production processes, demonstrating deep technical fluency in pharmaceutical compliance, GMP frameworks, and clinical supply chain integrity.